Mirtimash 30 Tablets

Mirtimash 30 Tablets

Description:

Mirtimash 30 Tablets is a prescription antidepressant medicine containing mirtazapine, a tetracyclic antidepressant from the piperazino-azepine group. It is formulated as 30 mg scored film-coated tablets, designed to help manage major depressive episodes by enhancing noradrenergic and serotonergic neurotransmission in the brain. Mirtimash is indicated for adults under medical supervision and is used as part of a comprehensive treatment plan for depression, helping to improve mood, sleep, appetite, and overall quality of life.

Indications:

• Treatment of major depressive disorder (MDD) in adults.
• Relief of core depressive symptoms such as persistent low mood, loss of interest or pleasure, feelings of worthlessness or guilt, and reduced energy.
• Management of associated symptoms of depression including anxiety, disturbed sleep (insomnia), and changes in appetite.
• May be used as part of a long-term maintenance regimen to help prevent relapse of depressive episodes, as directed by a psychiatrist or physician.

Active Ingredients / Key Components:

• Mirtazapine – 30 mg per film-coated tablet.
• Excipients (inactive ingredients) include standard tablet-forming agents and film-coating materials (exact excipient list and concentrations , please check the product leaflet or the manufacturer’s official website; please refer to the package insert for full details).

Dosage & Administration / How to Use:

• Mirtimash is for oral use only and should be taken exactly as prescribed by your doctor.
• Typical adult starting dose: 15–30 mg once daily, usually taken in the evening before bedtime. The dose may be adjusted by the physician up to a maximum of 45 mg per day depending on response and tolerability. (Exact regimen must be determined by the treating physician.)
• Swallow the tablet whole with a sufficient amount of water. The scored tablet allows dose adjustment if your doctor instructs you to split the tablet.
• Can be taken with or without food; taking it at the same time each day is recommended to maintain steady blood levels.
• Do not change the dose, stop, or restart treatment without consulting your doctor. Antidepressants may need several weeks before full benefit is observed.
• If you miss a dose and remember the same day, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule. Do not take a double dose to make up for a missed one.
• Duration of treatment is usually several months. Continue treatment as advised by your physician even if you start feeling better, to reduce the risk of relapse.

Clinical Benefits:

• Helps relieve symptoms of major depressive disorder by enhancing noradrenergic and serotonergic activity in the central nervous system.
• Improves mood, motivation, and overall emotional well-being in patients with depression.
• May improve sleep quality due to its antihistaminic properties, particularly beneficial in patients with insomnia associated with depression.
• Can help normalize appetite and weight in some patients experiencing appetite loss related to depression.
• Provides an alternative antidepressant option for patients who may not tolerate or respond adequately to other classes of antidepressants.

Warnings & Contraindications:

• Contraindicated in patients with known hypersensitivity to mirtazapine or any component of the formulation.
• Do not use in combination with monoamine oxidase inhibitors (MAOIs) or within 14 days of stopping an MAOI, and do not start an MAOI within 14 days of stopping mirtazapine, due to risk of serious drug interactions.
• Use with caution in patients with liver or kidney impairment, cardiovascular disease, low blood pressure, glaucoma, urinary retention, or a history of seizures.
• May increase the risk of suicidal thoughts and behaviors, especially at the beginning of treatment or when doses are changed, particularly in young adults. Close monitoring by a healthcare professional is essential.
• May cause sedation and impairment of cognitive and motor skills. Avoid driving, operating machinery, or performing tasks requiring alertness until you know how the medicine affects you.
• Alcohol: The impairment of cognitive and motor skills produced by mirtazapine is additive to those produced by alcohol. Patients are advised to avoid alcohol while taking Mirtimash.
• Drug interactions: Use with caution with other medicines that affect the central nervous system, serotonergic agents, or drugs metabolised by cytochrome p450 enzymes. Always inform your doctor about all medicines and supplements you are taking.
• Consult your doctor before use if pregnant or planning pregnancy. Mirtazapine should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
• Consult your doctor before use if breastfeeding; mirtazapine may pass into breast milk. A risk–benefit assessment is required.
• Not intended to diagnose, treat, cure, or prevent any disease without proper medical supervision.
• Keep out of reach of children.

Side Effects:

• Common side effects may include drowsiness or sedation, increased appetite, weight gain, dry mouth, dizziness, and constipation.
• Less common side effects can include headache, nausea, fatigue, abnormal dreams, or swelling of ankles or feet.
• Serious side effects (seek immediate medical attention) may include signs of allergic reaction (rash, itching, swelling of face or tongue, difficulty breathing), severe mood changes, suicidal thoughts, seizures, jaundice (yellowing of skin or eyes), or signs of infection such as fever, sore throat, or mouth ulcers (which may indicate blood cell changes).
• If you experience any unusual or persistent side effects, contact your doctor or pharmacist promptly.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children. Do not use after the expiry date printed on the pack. Store at or below the temperature specified on the original packaging (exact storage temperature is not available in the provided information; refer to the package insert).

Specifications:

• Form: Film-coated scored tablets.
• Strength: 30 mg mirtazapine per tablet.
• Count: 30 tablets per pack.
• Route of administration: Oral.
• Intended user group: Adults, under physician supervision.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.